A. Dalla Volta, G. Mazziotti, F. Maffezzoni, S. Grisanti, C. Palumbo, R. Pedersini, R. Maroldi, A. Berruti, Bone mineral density and FRAX score may not predict fracture risk in patients with cancer undergoing hormone deprivation therapies. J. Clin. Oncol. 38(29), 3363–3366 (2020). https://doi.org/10.1200/JCO.20.00434

Article  PubMed  Google Scholar 

G. Mazziotti, W. Vena, R. Pedersini, S. Piccini, E. Morenghi, D. Cosentini, P. Zucali, R. Torrisi, S. Sporeni, E.L. Simoncini, R. Maroldi, L. Balzarini, A.G. Lania, A. Berruti, Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice. J. Bone Oncol. 33, 100421 (2022). https://doi.org/10.1016/j.jbo.2022.100421

Article  PubMed  PubMed Central  Google Scholar 

S. Antonini, R. Pedersini, M.F. Birtolo, N.L. Baruch, F. Carrone, S. Jaafar, A. Ciafardini, D. Cosentini, M. Laganà, R. Torrisi, D. Farina, L. Leonardi, L. Balzarini, W. Vena, A.C. Bossi, A. Zambelli, A.G. Lania, A. Berruti, G. Mazziotti, Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors. J. Endocrinological Invest. (2023). https://doi.org/10.1007/s40618-023-02174-5

L. Cianferotti, C. Cipriani, S. Corbetta, G. Corona, G. Defeudis, A.G. Lania, C. Messina, N. Napoli, G. Mazziotti, Bone quality in endocrine diseases: determinants and clinical relevance. J. Endocrinological Investig. 46(7), 1283–1304 (2023). https://doi.org/10.1007/s40618-023-02056-w

Article  Google Scholar 

A. Dalla Volta, I. Caramella, P. Di Mauro, M. Bergamini, D. Cosentini, F. Valcamonico, C. Cappelli, M. Laganà, N. Di Meo, D. Farina, R. Pedersini, G. Mazziotti, A. Berruti, Role of body composition in the prediction of skeletal fragility induced by hormone deprivation therapies in cancer patients. Curr. Oncol. Rep. 25(10), 1141–1152 (2023). https://doi.org/10.1007/s11912-023-01447-9

Article  PubMed  PubMed Central  Google Scholar 

W. Vena, F. Carrone, A. Delbarba, O. Akpojiyovbi, L.C. Pezzaioli, P. Facondo, C. Cappelli, L. Leonardi, L. Balzarini, D. Farina, A. Pizzocaro, A.G. Lania, G. Mazziotti, A. Ferlin, Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome. J. Endocrinological Investig. 46(2), 297–304 (2023). https://doi.org/10.1007/s40618-022-01901-8

Article  Google Scholar 

C. Cooper, E.J. Atkinson, W.M. O’Fallon, L.J. Melton 3rd, Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J. Bone Miner. Res. 7(2), 221–227 (1992). https://doi.org/10.1002/jbmr.5650070214

Article  PubMed  Google Scholar 

M.M. van Oostwaard, J.P. van den Bergh, Y. van de Wouw, M. Janssen-Heijnen, M. de Jong, C.E. Wyers, High prevalence of vertebral fractures at initiation of androgen deprivation therapy for prostate cancer. J. Bone Oncol. 38, 100465 (2023). https://doi.org/10.1016/j.jbo.2022.100465

Article  PubMed  Google Scholar 

C.M. Klotzbuecher, P.D. Ross, P.B. Landsman, T.A. Abbott 3rd, M. Berger, Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J. Bone Miner. Res. 15(4), 721–739 (2000). https://doi.org/10.1359/jbmr.2000.15.4.721

Article  PubMed  Google Scholar 

G. Mazziotti, M. Rodari, F. Gelardi, G. Tosi, P.A. Zucali, G. Pepe, A. Chiti, Morphometric vertebral fractures in patients with castration-resistant prostate cancer undergoing treatment with radium-223: a longitudinal study in the real-life clinical practice. Endocrine 69(1), 204–211 (2020). https://doi.org/10.1007/s12020-020-02277-6

Article  PubMed  Google Scholar 

L. Johansson, H. Johansson, K.F. Axelsson, H. Litsne, N.C. Harvey, E. Liu, W.D. Leslie, L. Vandenput, E. McCloskey, J.A. Kanis, M. Lorentzon, Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX. Osteoporos. Int. 33(8), 1725–1738 (2022). https://doi.org/10.1007/s00198-022-06387-x

Article  PubMed  PubMed Central  Google Scholar 

J.A. Kanis, O. Johnell, A. Oden, H. Johansson, E. McCloskey, FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos. Int. 19(4), 385–397 (2008). https://doi.org/10.1007/s00198-007-0543-5

Article  PubMed  PubMed Central  Google Scholar 

J.A. Kanis, N.C. Harvey, C. Cooper, H. Johansson, A. Odén, E.V. McCloskey, A systematic review of intervention thresholds based on FRAX : a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch. Osteoporos. 11(1), 25 (2016). https://doi.org/10.1007/s11657-016-0278-z

Article  PubMed  PubMed Central  Google Scholar 

C. Ye, S.N. Morin, L.M. Lix, E.V. McCloskey, H. Johansson, N.C. Harvey, J.A. Kanis, W.D. Leslie, Performance of FRAX in men with prostate cancer: a registry-based cohort study. J. Bone Miner. Res. 38(5), 659–664 (2023). https://doi.org/10.1002/jbmr.4793

Article  PubMed  Google Scholar 

W.D. Leslie, E.S. Orwoll, C.M. Nielson, S.N. Morin, S.R. Majumdar, H. Johansson, A. Odén, E.V. McCloskey, J.A. Kanis, Estimated lean mass and fat mass differentially affect femoral bone density and strength index but are not FRAX independent risk factors for fracture. J. Bone Miner. Res. 29(11), 2511–2519 (2014). https://doi.org/10.1002/jbmr.2280

Article  PubMed  Google Scholar 

C. De Laet, J.A. Kanis, A. Oden, H. Johanson, O. Johnell, P. Delmas, J.A. Eisman, H. Kroger, S. Fujiwara, P. Garnero, E.V. McCloskey, D. Mellstrom, L.J. Melton 3rd, P.J. Meunier, H.A. Pols, J. Reeve, A. Silman, A. Tenenhouse, Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos. Int. 16(11), 1330–1338 (2005). https://doi.org/10.1007/s00198-005-1863-y

Article  PubMed  Google Scholar 

S. D’Andrea, A. Martorella, F. Coccia, C. Castellini, E. Minaldi, M. Totaro, A. Parisi, F. Francavilla, S. Francavilla, A. Barbonetti, Relationship of Vitamin D status with testosterone levels: a systematic review and meta-analysis. Endocrine 72(1), 49–61 (2021). https://doi.org/10.1007/s12020-020-02482-3

Article  PubMed  Google Scholar 

V. Hirani, R.G. Cumming, V. Naganathan, F. Blyth, D.G. Le Couteur, B. Hsu, D.J. Handelsman, L.M. Waite, M.J. Seibel, Longitudinal associations between vitamin d metabolites and sarcopenia in older Australian men: the concord health and aging in men project. J. Gerontol. Ser. A, Biol. Sci. Med. Sci. 73(1), 131–138 (2017). https://doi.org/10.1093/gerona/glx086

Article  Google Scholar 

C. Palumbo, A. Dalla Volta, S. Zamboni, G. Mazziotti, M. Zamparini, L. Triggiani, P. Borghetti, F. Maffezzoni, R. Bresciani, L. Rinaudo, F. Valcamonico, D. Farina, S.M. Magrini, A. Antonelli, C. Simeone, A. Berruti, Effect of degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study. J. Clin. Endocrinol. Metab. 107(12), 3398–3407 (2022). https://doi.org/10.1210/clinem/dgac489

Article  PubMed  Google Scholar